구강 작열감 증후군의 진단 및 치료
Burning Mouth Syndrome
4
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Burning mouth syndrome (BMS) is defined as a chronic pain condition, characterized symptomatically by a generalized or localized burning sensation in the oral cavity without any specific mucosal lesion. Although this is not a rare disease, the etiology and effective treatment are not well established yet. Various drugs have been used in attempting to manage BMS, but there is insufficient evidence to show the effect of them. The goal of this article is to review about diagnosis, treatment, and updates current knowledge of BMS along with our experiences. Although randomized controlled studies are required to establish the treatment for patients suffering from this chronic and painful syndrome, the authors hope that this document will encourage otolaryngologist to approach to this challenging disease without fear and contribute to a better therapeutic management.
Abstract
Burning mouth syndrome (BMS) is defined as a chronic pain condition, characterized symptomatically by a generalized or localized burning sensation in the oral cavity without any specific mucosal lesion. Although this is not a rare disease, the etiology and effective treatment are not well established yet. Various drugs have been used in attempting to manage BMS, but there is insufficient evidence to show the effect of them. The goal of this article is to review about diagnosis, treatment, and updates current knowledge of BMS along with our experiences. Although randomized controlled studies are required to establish the treatment for patients suffering from this chronic and painful syndrome, the authors hope that this document will encourage otolaryngologist to approach to this challenging disease without fear and contribute to a better therapeutic management.
참고문헌 (25)
- Crow HC, "Burning mouth syndrome", Oral Maxillofac Surg Clin North Am, 25(1), pp.67~76 (2013)
- Spanemberg JC, "Aetiology and therapeutics of burning mouth syndrome: an update", Gerodontology, 29(2), pp.84~89 (2012)
- Klasser GD, "Management of burning mouth syndrome", J Mich Dent Assoc, 94(6), pp.43~46 (2012)
- Sardella A, "An up-to-date view on burning mouth syndrome", Minerva Stomatol, 56(6), pp.327~340 (2007)
- Ni Riordain R, "Patient-reported outcome measures in burning mouth syndrome - a review of the literature", Oral Dis (2012)
- Zur E, "Burning mouth syndrome: a discussion of a complex pathology", Int J Pharm Compd, 16(3), pp.196~205 (2012)
- Pigatto PD, "Burning mouth syndrome", Skinmed, 10(3), pp.134~135 (2012)
- Abetz LM, "Burning mouth syndrome and psychological disorders", Aust Dent J, 54(2), pp.84~173 (2009)
- López-Jornet P, "Burning mouth syndrome, oral parafunctions, and psychological profile in a longitudinal case study", J Eur Acad Dermatol Venereol, 23(3), pp.363~365 (2009)
- de Moraes M, "Randomized trials for the treatment of burning mouth syndrome: an evidence-based review of the literature", J Oral Pathol Med, 41(4), pp.281~287 (2012)
- Femiano F, "Burning Mouth Syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy", Med Oral, 9(1), pp.8~13 (2004)
- López-D’alessandro E, "Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial", Med Oral Patol Oral Cir Bucal, 16(5), pp.e635~e640 (2011)
- Silvestre FJ, "Application of a capsaicin rinse in the treatment of burning mouth syndrome", Oral Patol Oral Cir Bucal, 17(1), pp.e1~e4 (2012)
- Lauritano D, "Preliminary protocol for systemic administration of capsaicin for the treatment of the burning mouth syndrome", Minerva Stomatol, 52(6), pp.273~278 (2003)
- Grushka M, "An open-label, dose escalation pilot study of the effect of clonazepam in burning mouth syndrome", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 86(5), pp.557~561 (1998)
- Heckmann SM, "Gabapentin has little or no effect in the treatment of burning mouth syndrome - results of an open-label pilot study", Eur J Neurol, 13(7), pp.e6~e7 (2006)
- 정연훈, "구강작열감 증후군 환자의 임상적 특징 및 스테로이드 가글 치료의 예비결과", 대한이비인후과학회지 두경부외과학, 47(6), pp.569~574 (2004), 대한이비인후과학회
- 박하나로, "구강 작열 증후군과 혈액학적 이상 사이의 상관 관계에 대한 분석", 대한이비인후과학회지 두경부외과학, 56(1), pp.23~27 (2013), 대한이비인후과학회[DOI]
- Scala A, "Update on burning mouth syndrome: overview and patient management", Crit Rev Oral Biol Med, 14(4), pp.275~291 (2003)
- Carbone M, "Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a doubleblind, randomized, placebo-controlled study", Eur J Pain, 13(5), pp.492~496 (2009)
- Cavalcanti DR, "Alpha lipoic acid in burning mouth syndrome--a randomized double-blind placebo-controlled trial", J Oral Pathol Med, 38(3), pp.254~261 (2009)
- Marino R, "Different therapeutic strategies for burning mouth syndrome: preliminary data", J Oral Pathol Med, 39(8), pp.611~616 (2010)
- Petruzzi M, "Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study", J Oral Pathol Med, 33(2), pp.111~114 (2004)
- Heckmann SM, "A double-blind study on clonazepam in patients with burning mouth syndrome", Laryngoscope, 122(4), pp.813~816 (2012)
- Gremeau-Richard C, "Topical clonazepam in stomatodynia: a randomised placebo-controlled study", Pain, 108(1-2), pp.51~57 (2004)